CONCORD BIOTECH
Back to All Ratios
|
CONCORD BIOTECH Last 5 Year EBIT Margin History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|
EBIT Margin(%) | 37.22 | 33.56 | 49.89 | 41.07 |
What is the latest EBIT Margin ratio of CONCORD BIOTECH ?
Year | EBIT Margin |
---|---|
Mar2023 | 37.22 |
Mar2022 | 33.56 |
Mar2021 | 49.89 |
Mar2020 | 41.07 |
How is EBIT Margin of CONCORD BIOTECH Trending?
Years | EBIT Margin | % Change | |
---|---|---|---|
Mar2023 | 37.22 | 10.91 | |
Mar2022 | 33.56 | -32.73 | |
Mar2021 | 49.89 | 21.48 | |
Mar2020 | 41.07 | - |
Other Financial Ratios of CONCORD BIOTECH
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EBIT Margin ratio of peers of CONCORD BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CONCORD BIOTECH | ₹14,558.2 Cr | -4.6% | -16% | NA | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹351,467.0 Cr | -4.9% | -2.6% | 54% | Stock Analytics | |
CIPLA | ₹119,470.0 Cr | -0.1% | 5% | 57.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹116,563.0 Cr | 8.1% | 9.1% | 25.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹105,690.0 Cr | -2.4% | 10.8% | 110% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,351.1 Cr | 1.4% | -4.8% | 30.2% | Stock Analytics |
CONCORD BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CONCORD BIOTECH | -4.6% |
-16% |
|
SENSEX | 1.7% |
1.1% |
21.3% |
You may also like the below Video Courses